Synonyms
Splenic lymphoma with villous lymphocytes
Definition
The term splenic marginal zone lymphoma (SMZL) was initially proposed by Schmid and Isaacson in 1992 (Schmid et al. 1992) for describing a B-cell lymphoma involving the spleen with a micronodular infiltration pattern and a peculiar morphology suggesting marginal zone origin. The splenic histology and peripheral blood features in these cases was overlapping with those found in the condition termed as “splenic lymphoma with villous lymphocytes” (Matutes et al. 1994); thus both conditions were assumed to represent the same lymphoproliferative disorder and integrated into a single condition, denominated as splenic marginal zone lymphoma.
The use of the term “marginal zone lymphoma” (MZL) has been frequently understood as indicating a close relationship to the other marginal zone–derived tumors, marginal zone lymphoma in mucosa-associated lymphoid tissue (MZL-MALT), and nodal MZL. However, the clinical, immunophenotypic, and...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
Audouin, J., Le Tourneau, A., Molina, T., Camilleri-Broet, S., Adida, C., Comperat, E., Benattar, L., Delmer, A., Devidas, A., Rio, B., & Diebold, J. (2003). Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes. British Journal of Haematology, 122(3), 404–412.
Baseggio, L., Traverse-Glehen, A., Petinataud, F., Callet-Bauchu, E., Berger, F., Ffrench, M., Couris, C. M., Thieblemont, C., Morel, D., Coiffier, B., Salles, G., & Felman, P. (2010). CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica 95(4), 604–612.
Curiel-Olmo, S., Mondejar, R., Almaraz, C., Mollejo, M., Cereceda, L., Mares, R., Derdak, S., Campos-Martin, Y., Batlle, A., Gonzalez de Villambrosia, S., Gut, M., Blanc, J., Traverse-Glehen, A., Verney, A., Baseggio, L., Camacho, F. I., Wotherspoon, A., Stamatopoulos, K., Xochelli, A., Papadaki, T., Kanellis, G., Ponzoni, M., Garcia-Cosio, M., Vaque, J. P., Beltran, S., Gut, I., Piris, M. A., & Martinez, N. (2017). Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood 129(8), 1042–1045.
Franco, V., Florena, A. M., & Campesi, G. (1996). Intrasinusoidal bone marrow infiltration: A possible hallmark of splenic lymphoma. Histopathology, 29(6), 571–575.
Hamadeh, F., MacNamara, S. P., Aguilera, N. S., Swerdlow, S. H., Cook, J. R. (2014). MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma. Modern Pathology.
Jallades, L., Baseggio, L., Sujobert, P., Huet, S., Chabane, K., Callet-Bauchu, E., Verney, A., Hayette, S., Desvignes, J. P., Salgado, D., Levy, N., Beroud, C., Felman, P., Berger, F., Magaud, J. P., Genestier, L., Salles, G., & Traverse-Glehen, A. (2017). Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica 102(10), 1758–1766.
Jimenez, C., Sebastian, E., Chillon, M. C., Giraldo, P., Mariano Hernandez, J., Escalante, F., Gonzalez-Lopez, T. J., Aguilera, C., de Coca, A. G., Murillo, I., Alcoceba, M., Balanzategui, A., Sarasquete, M. E., Corral, R., Marin, L. A., Paiva, B., Ocio, E. M., Gutierrez, N. C., Gonzalez, M., San Miguel, J. F., & Garcia-Sanz, R. (2013). MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom’s macroglobulinemia. Leukemia 27(8), 1722–1728.
Kanellis, G., Mollejo, M., Montes-Moreno, S., Rodriguez-Pinilla, S. M., Cigudosa, J. C., Algara, P., Montalban, C., Matutes, E., Wotherspoon, A., & Piris, M. A. (2010). Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica 95(7), 1122–1129.
Kiel, M. J., Velusamy, T., Betz, B. L., Zhao, L., Weigelin, H. G., Chiang, M. Y., Huebner-Chan, D. R., Bailey, N. G., Yang, D. T., Bhagat, G., Miranda, R. N., Bahler, D. W., Medeiros, L. J., Lim, M. S., & Elenitoba-Johnson, K. S. (2012). Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. Journal of Experimental Medicine, 209(9), 1553–1565.
Liu, L., Wang, H., Chen, Y., Rustveld, L., Liu, G., & Du, X. L. (2013). Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States. Leuk Lymphoma 54(7), 1380–1386.
Martinez-Lopez, A., Curiel-Olmo, S., Mollejo, M., Cereceda, L., Martinez, N., Montes-Moreno, S., Almaraz, C., Revert, J. B., & Piris, M. A. (2015). MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol 39(5), 644–651.
Martinez, N., Almaraz, C., Vaque, J. P., Varela, I., Derdak, S., Beltran, S., Mollejo, M., Campos-Martin, Y., Agueda, L., Rinaldi, A., Kwee, I., Gut, M., Blanc, J., Oscier, D., Strefford, J. C., Martinez-Lopez, J., Salar, A., Sole, F., Rodriguez-Peralto, J. L., Diez-Tascon, C., Garcia, J. F., Fraga, M., Sebastian, E., Alves, J., Menarguez, J., Gonzalez-Carrero, J., Casado, L. F., Bayes, M., Bertoni, F., Gut, I., & Piris, M. A. (2014). Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Leukemia, 28(6), 1334–1340.
Mateo, M., Mollejo, M., Villuendas, R., Algara, P., Sanchez-Beato, M., Martinez, P., & Piris, M. A. (1999). 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. American Journal of Pathology, 154(5), 1583–1589.
Matutes, E., Morilla, R., Owusu-Ankomah, K., Houlihan, A., & Catovsky, D. (1994). The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood, 83(6), 1558–1562.
Matutes, E., Oscier, D., Montalban, C., Berger, F., Callet-Bauchu, E., Dogan, A., Felman, P., Franco, V., Iannitto, E., Mollejo, M., Papadaki, T., Remstein, E. D., Salar, A., Sole, F., Stamatopoulos, K., Thieblemont, C., Traverse-Glehen, A., Wotherspoon, A., Coiffier, B., & Piris, M. A. (2008). Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia, 22(3), 487–495.
Mollejo, M., Lloret, E., Menarguez, J., Piris, M. A., & Isaacson, P. G. (1997). Lymph node involvement by splenic marginal zone lymphoma: Morphological and immunohistochemical features. American Journal of Surgical Pathology, 21(7), 772–780.
Montalban, C., Abraira, V., Arcaini, L., Domingo-Domenech, E., Guisado-Vasco, P., Iannitto, E., Mollejo, M., Matutes, E., Ferreri, A. J., Salar, A., Rattotti, S., Carpaneto, A., Perez, R., Bello, J. L., Hernandez, M., Caballero, D., Carbonell, F., Piris, M. A., & Splenic Marginal Zone Lymphoma Study, G. (2014). Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use. Leuk Lymphoma 55(4), 929–931.
Piva, R., Deaglio, S., Fama, R., Buonincontri, R., Scarfo, I., Bruscaggin, A., Mereu, E., Serra, S., Spina, V., Brusa, D., Garaffo, G., Monti, S., Dal Bo, M., Marasca, R., Arcaini, L., Neri, A., Gattei, V., Paulli, M., Tiacci, E., Bertoni, F., Pileri, S. A., Foa, R., Inghirami, G., Gaidano, G., Rossi, D. (2014). The Kruppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia.
Ponzoni, M., Kanellis, G., Pouliou, E., Baliakas, P., Scarfo, L., Ferreri, A. J., Doglioni, C., Bikos, V., Dagklis, A., Anagnostopoulos, A., Ghia, P., Stamatopoulos, K., & Papadaki, T. (2012). Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: A reliable substitute for spleen histopathology? American Journal of Surgical Pathology, 36(11), 1609–1618.
Rossi, D., Trifonov, V., Fangazio, M., Bruscaggin, A., Rasi, S., Spina, V., Monti, S., Vaisitti, T., Arruga, F., Fama, R., Ciardullo, C., Greco, M., Cresta, S., Piranda, D., Holmes, A., Fabbri, G., Messina, M., Rinaldi, A., Wang, J., Agostinelli, C., Piccaluga, P. P., Lucioni, M., Tabbo, F., Serra, R., Franceschetti, S., Deambrogi, C., Daniele, G., Gattei, V., Marasca, R., Facchetti, F., Arcaini, L., Inghirami, G., Bertoni, F., Pileri, S. A., Deaglio, S., Foa, R., Dalla-Favera, R., Pasqualucci, L., Rabadan, R., & Gaidano, G. (2012). The coding genome of splenic marginal zone lymphoma: Activation of NOTCH2 and other pathways regulating marginal zone development. Journal of Experimental Medicine, 209(9), 1537–1551.
Schmid, C., Kirkham, N., Diss, T., & Isaacson, P. G. (1992). Splenic marginal zone cell lymphoma. American Journal of Surgical Pathology, 16(5), 455–466.
Troen, G., Warsame, A., & Delabie, J. (2013). CD79B and MYD88 mutations in splenic marginal zone lymphoma. ISRN Oncology, 2013, 252318.
Xochelli, A., Bikos, V., Polychronidou, E., Galigalidou, C., Agathangelidis, A., Charlotte, F., Moschonas, P., Davis, Z., Colombo, M., Roumelioti, M., Sutton, L. A., Groenen, P., van den Brand, M., Boudjoghra, M., Algara, P., Traverse-Glehen, A., Ferrer, A., Stalika, E., Karypidou, M., Kanellis, G., Kalpadakis, C., Mollejo, M., Pangalis, G., Vlamos, P., Amini, R. M., Pospisilova, S., Gonzalez, D., Ponzoni, M., Anagnostopoulos, A., Giudicelli, V., Lefranc, M. P., Espinet, B., Panagiotidis, P., Piris, M. A., Du, M. Q., Rosenquist, R., Papadaki, T., Belessi, C., Ferrarini, M., Oscier, D., Tzovaras, D., Ghia, P., Davi, F., Hadzidimitriou, A., & Stamatopoulos, K. (2019). Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations. Journal of Pathology,247(4): 416–421.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Mollejo, M., Piris, M.A. (2020). Splenic Marginal Zone Lymphoma. In: Molina, T.J. (eds) Hematopathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-95309-0_1938
Download citation
DOI: https://doi.org/10.1007/978-3-319-95309-0_1938
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95308-3
Online ISBN: 978-3-319-95309-0
eBook Packages: MedicineReference Module Medicine